SVRA: מחיר למכירות Savara Corp

Savara Inc. aims for dominance in the therapy of rare pulmonary proteinosis by implementing targeted delivery of biologics to inflammation sites. The GURU.Markets portal displays this P/S time series, where the metric value of captures the current revenue valuation. Since the company is in the pre-commercial stage, future price momentum depends directly on final regulatory decisions.

The P/S ratio is calculated as the ratio of Savara Inc. (SVRA) market capitalization to its annual revenue, determining the value of one dollar of sales in the eyes of investors. Analyzing the price-to-sales ratio allows for an assessment of the efficiency of biopharmaceutical logistics costs, where the stability of clinic supplies directly impacts the asset's fundamental resilience and the justification of current market valuations.